반응식
C1(C(C2C=CC=CC=2)(C2C=CC=CC=2)[N:8]2[C:12]3[CH:13]=[CH:14][C:15]([C:17]([O:19]C)=O)=[CH:16][C:11]=3[N:10]=[CH:9]2)C=CC=CC=1.Cl.[Cl:34][C:35]1[CH:36]=[C:37]2[C:42](=[CH:43][CH:44]=1)[CH:41]=[C:40]([S:45]([N:48]1[CH2:53][CH2:52][NH:51][CH2:50][CH2:49]1)(=[O:47])=[O:46])[CH:39]=[CH:38]2>>[ClH:34].[N:8]1[C:12]2[CH:13]=[CH:14][C:15]([C:17]([N:51]3[CH2:50][CH2:49][N:48]([S:45]([C:40]4[CH:39]=[CH:38][C:37]5[C:42](=[CH:43][CH:44]=[C:35]([Cl:34])[CH:36]=5)[CH:41]=4)(=[O:47])=[O:46])[CH2:53][CH2:52]3)=[O:19])=[CH:16][C:11]=2[NH:10][CH:9]=1참가 물질
3
실험 절차
In a similar manner to Example 3, 4 or 10 except for the use of methyl N-triphenylmethyl-5-benzimidazolecarboxylate and 1-[(6-chloronaphthalen-2-yl)sulfonyl]piperazine hydrochloride as the raw materials, the reaction was conducted, whereby the title compound was obtained.
출처 및 근거
- ORD 기록
- ord-a73e571d7ac04ca0b21ca62678230f50
- 출처 데이터셋
- uspto-grants-2003_02
- 특허 번호
- US06525042B1
연결된 노트
불러오는 중…